Clinical Trial Update: Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update from Novartis evaluated patient preference, satisfaction, and correct use of inhalers in chronic obstructive pulmonary diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED | Results posted: 2017-01-06